Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.

Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN.

Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12.

PMID:
30442501
2.

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma.

Morandi F, Amoroso L, Dondero A, Castriconi R, Parodi S, Luksch R, Casale F, Castellano A, Garaventa A, Moretta A, Bottino C, Ponzoni M, Corrias MV.

Oncoimmunology. 2018 Jul 30;7(9):e1468953. doi: 10.1080/2162402X.2018.1468953. eCollection 2018.

PMID:
30357053
3.

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.

Camisaschi C, Renne SL, Beretta V, Rini F, Spagnuolo RD, Tuccitto A, Podda MG, Parmiani G, Rivoltini L, Collini P, Castelli C, Luksch R.

BMC Cancer. 2018 Oct 16;18(1):983. doi: 10.1186/s12885-018-4910-8.

4.

Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.

Faraci M, Bertaina A, Luksch R, Calore E, Lanino E, Saglio F, Prete A, Menconi M, De Simone G, Tintori V, Cesaro S, Santarone S, Orofino MG, Locatelli F, Zecca M.

Biol Blood Marrow Transplant. 2019 Feb;25(2):313-320. doi: 10.1016/j.bbmt.2018.09.027. Epub 2018 Sep 26.

PMID:
30266674
5.

Peripheral neuroblastic tumor of the kidney: case report and review of literature.

Moscheo C, Campari A, Podda MG, Riccipetitoni G, Collini P, Renne SL, Vella C, Napolitano M, Luksch R.

Tumori. 2018 Jul 1:300891618788475. doi: 10.1177/0300891618788475. [Epub ahead of print]

PMID:
30021475
6.

Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.

Morgenstern DA, Pötschger U, Moreno L, Papadakis V, Owens C, Ash S, Pasqualini C, Luksch R, Garaventa A, Canete A, Elliot M, Wieczorek A, Laureys G, Kogner P, Malis J, Ruud E, Beck-Popovic M, Schleiermacher G, Valteau-Couanet D, Ladenstein R.

Pediatr Blood Cancer. 2018 Nov;65(11):e27363. doi: 10.1002/pbc.27363. Epub 2018 Jul 17.

PMID:
30015396
7.

Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.

Esposito MR, Binatti A, Pantile M, Coppe A, Mazzocco K, Longo L, Capasso M, Lasorsa VA, Luksch R, Bortoluzzi S, Tonini GP.

Int J Cancer. 2018 Nov 15;143(10):2525-2536. doi: 10.1002/ijc.31748. Epub 2018 Sep 17.

PMID:
29992558
8.

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis.

Corrias MV, Parodi S, Tchirkov A, Lammens T, Vicha A, Pasqualini C, Träger C, Yáñez Y, Dallorso S, Varesio L, Luksch R, Laureys G, Valteau-Couanet D, Canete A, Pöetschger U, Ladenstein R, Burchill SA.

Pediatr Blood Cancer. 2018 Jul;65(7):e27052. doi: 10.1002/pbc.27052. Epub 2018 Mar 30.

9.

Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.

Meazza C, Cefalo G, Massimino M, Daolio P, Pastorino U, Scanagatta P, Morosi C, Podda M, Ferrari A, Terenziani M, Spreafico F, Casanova M, Parafioriti A, Collini P, Gandola L, Bastoni S, Biassoni V, Schiavello E, Chiaravalli S, Puma N, Bergamaschi L, Luksch R.

Med Oncol. 2017 Nov 1;34(12):191. doi: 10.1007/s12032-017-1052-9.

PMID:
29094224
10.

Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.

Luksch R, Grignani G, D'Angelo P, Prete A, Puma N, Podda M, Casanova M, Ferrari A, Morosi C, Fagioli F, Aglietta M, Ferrari S, Picci P, Massimino M.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26650. Epub 2017 Jun 14.

PMID:
28612488
11.

Searching for Happiness.

Ferrari A, Gaggiotti P, Silva M, Veneroni L, Magni C, Signoroni S, Casanova M, Luksch R, Terenziani M, Spreafico F, Meazza C, Clerici CA, Massimino M.

J Clin Oncol. 2017 Jul 1;35(19):2209-2212. doi: 10.1200/JCO.2017.72.8733. Epub 2017 Apr 27. No abstract available.

PMID:
28448240
12.

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study.

Amoroso L, Erminio G, Makin G, Pearson ADJ, Brock P, Valteau-Couanet D, Castel V, Pasquet M, Laureys G, Thomas C, Luksch R, Ladenstein R, Haupt R, Garaventa A; SIOPEN Group.

Cancer Res Treat. 2018 Jan;50(1):148-155. doi: 10.4143/crt.2016.511. Epub 2017 Mar 21.

13.

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D; SIOP Europe Neuroblastoma Group (SIOPEN).

Lancet Oncol. 2017 Apr;18(4):500-514. doi: 10.1016/S1470-2045(17)30070-0. Epub 2017 Mar 2.

PMID:
28259608
14.

Neuroblastoma (Peripheral neuroblastic tumours).

Luksch R, Castellani MR, Collini P, De Bernardi B, Conte M, Gambini C, Gandola L, Garaventa A, Biasoni D, Podda M, Sementa AR, Gatta G, Tonini GP.

Crit Rev Oncol Hematol. 2016 Nov;107:163-181. doi: 10.1016/j.critrevonc.2016.10.001. Epub 2016 Oct 6. Review.

PMID:
27823645
15.

When curing a pediatric tumor is not enough: the case of a psychiatric disorder in a woman surviving osteosarcoma.

Meazza C, Veneroni L, Podda M, Terenziani M, Luksch R, Ferrari A, Catania S, Schiavello E, Giacon B, Puma N, Bergamaschi L, Roncari L, Clerici CA.

Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000417.

PMID:
26481864
16.

Measuring the efficacy of a project for adolescents and young adults with cancer: A study from the Milan Youth Project.

Ferrari A, Silva M, Veneroni L, Magni C, Clerici CA, Meazza C, Terenziani M, Spreafico F, Chiaravalli S, Casanova M, Luksch R, Catania S, Schiavello E, Biassoni V, Podda M, Bergamaschi L, Puma N, Indini A, Proserpio T, Massimino M.

Pediatr Blood Cancer. 2016 Dec;63(12):2197-2204. doi: 10.1002/pbc.26172. Epub 2016 Aug 24.

PMID:
27554940
17.

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.

Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, Ferrari A.

Oncotarget. 2016 Sep 13;7(37):58903-58914. doi: 10.18632/oncotarget.10368.

18.

Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.

Parafioriti A, Bason C, Armiraglio E, Calciano L, Daolio PA, Berardocco M, Di Bernardo A, Colosimo A, Luksch R, Berardi AC.

Int J Mol Sci. 2016 Apr 30;17(5). pii: E656. doi: 10.3390/ijms17050656.

19.

Oral etoposide in relapsed or refractory Ewing sarcoma: a monoinstitutional experience in children and adolescents.

Podda MG, Luksch R, Puma N, Gandola L, Morosi C, Terenziani M, Ferrari A, Casanova M, Spreafico F, Meazza C, Catania S, Schiavello E, Biassoni V, Chiaravalli S, Massimino M.

Tumori. 2016 Jan-Feb;102(1):84-8. doi: 10.5301/tj.5000419. Epub 2015 Oct 28.

PMID:
26797935
20.

The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study.

Ferrari A, Lo Vullo S, Giardiello D, Veneroni L, Magni C, Clerici CA, Chiaravalli S, Casanova M, Luksch R, Terenziani M, Spreafico F, Meazza C, Catania S, Schiavello E, Biassoni V, Podda M, Bergamaschi L, Puma N, Massimino M, Mariani L.

Pediatr Blood Cancer. 2016 Mar;63(3):479-85. doi: 10.1002/pbc.25833. Epub 2015 Nov 24.

PMID:
26797893

Supplemental Content

Loading ...
Support Center